Business - Briefly   

Sun Pharma mulls demerger of R&D unit

MUMBAI: Sun Pharmaceutical Industries on Friday said it would consider demerger of its research and development unit into a new company. The board of directors will meet on February 9 to consider the proposal, it informed the BSE.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

Sensex drops 101 points
SC declines to stay trial of Lodha
Birlas demand resignation
Siemens' turbine unit in Gujarat
Satyam unveils centre of excellence in Detroit
Rupee recovers
Birla MF hopes to raise Rs. 1,000 cr. through new fund
Java developer meet in Chennai
Exchange rates
Bullion rates
Marginal rise in inflation
DCA's e-governance launch on Feb. 18
Reliance Energy bids for Mumbai Metro
FMC gets tough with NCDEX
S.Korea-U.S. FTA talks begin
Sanjeev Aga to head COAI
L&T acquires Spectrum Infotech
Merck seeks shareholder nod for hiving off unit
Sun Pharma mulls demerger of R&D unit
PSI Data partners Lawson Software
Platinum jubilee of Karnataka Bank's branch
Prolease renamed as TalentPro
UTI Leadership Fund mobilises Rs. 2,000 cr.
Scandent division bags $34 m order
Quintegra forays into Asia Pacific region
Banswara Syntex bags export order

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu